Travestis, transgender women and young MSM are at high risk for PrEP early loss to follow-up in Rio de Janeiro, Brazil

INTRODUCTION: Oral pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir (FTC/TDF) is highly effective in preventing HIV infection. This study aimed to identify factors associated with PrEP early loss to follow-up (ELFU) among gay, bisexual and other men who have sex with men (MSM), travestis...

Descripción completa

Detalles Bibliográficos
Autores principales: Echeverría-Guevara, Amanda, Coelho, Lara E., Veloso, Valdiléa G., Pimenta, Maria C., Hoagland, Brenda, Moreira, Ronaldo I., Leite, Iuri, Jalil, Emília M., Cardoso, Sandra W., Torres, Thiago S., Grinsztejn, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871061/
https://www.ncbi.nlm.nih.gov/pubmed/36586721
http://dx.doi.org/10.1016/j.bjid.2022.102733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871061/
https://www.ncbi.nlm.nih.gov/pubmed/36586721
http://dx.doi.org/10.1016/j.bjid.2022.102733

Ejemplares similares